Literature DB >> 12479793

Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation.

YunJin Jung1, Jennifer S Isaacs, Sunmin Lee, Jane Trepel, Zheng-Gang Liu, Len Neckers.   

Abstract

Tumour necrosis factor alpha (TNF-alpha) binds to its receptor (TNFR1) and activates both death- and inflammation/survival-related signalling pathways. The inflammation and survival-related signalling cascade results in the activation of the transcription factor, nuclear factor kappa B (NF-kappa B) and requires recruitment of receptor-interacting protein (RIP) to TNFR1. The indispensable role of RIP in TNF-induced NF-kappa B activation has been demonstrated in RIP(-/-) mice and in cell lines derived from such mice. In the present study, we show that the TNF-alpha-induced accumulation of hypoxia-inducible factor 1 alpha (HIF-1 alpha) protein in normoxic cells is RIP-dependent. Exposing fibroblasts derived from RIP(-/-) mice to either cobalt or PMA resulted in an equivalent HIF-1 alpha induction to that seen in RIP(+/+) fibroblasts. In contrast, RIP(-/-) cells were unable to induce HIF-1 alpha in response to TNF-alpha. Further, transient transfection of NIH 3T3 cells with an NF-kappa B super-repressor plasmid (an inhibitor of NF-kappa B activation) also prevented HIF-1 alpha induction by TNF-alpha. Surprisingly, although HIF-1 alpha mRNA levels remained unchanged after induction by TNF, induction of HIF-1 alpha protein by the cytokine was completely blocked by pretreatment with the transcription inhibitors actinomycin D and 5,6-dichlorobenzimidazole riboside. Finally, TNF failed to induce both HIF-1 alpha, made resistant to von Hippel-Lindau (VHL), and wild-type HIF-1 alpha transfected into VHL(-/-) cells. These results indicate that HIF-1 alpha induction by TNF-alpha in normoxic cells is mediated by protein stabilization but is nonetheless uniquely dependent on NF-kappa B-driven transcription. Thus the results describe a novel mechanism of HIF-1 alpha up-regulation and they identify HIF-1 alpha as a unique component of the NF-kappa B-mediated inflammatory/survival response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12479793      PMCID: PMC1223232          DOI: 10.1042/BJ20021279

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.

Authors:  S Salceda; J Caro
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

Review 2.  Erythropoietin in the treatment of anemia in chronic infectious, inflammatory, and malignant diseases.

Authors:  R T Means
Journal:  Curr Opin Hematol       Date:  1995-05       Impact factor: 3.284

Review 3.  Activation of the HIF pathway in cancer.

Authors:  P H Maxwell; C W Pugh; P J Ratcliffe
Journal:  Curr Opin Genet Dev       Date:  2001-06       Impact factor: 5.578

4.  In vivo expression of mRNAs encoding hypoxia-inducible factor 1.

Authors:  C M Wiener; G Booth; G L Semenza
Journal:  Biochem Biophys Res Commun       Date:  1996-08-14       Impact factor: 3.575

5.  V-SRC induces expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes encoding vascular endothelial growth factor and enolase 1: involvement of HIF-1 in tumor progression.

Authors:  B H Jiang; F Agani; A Passaniti; G L Semenza
Journal:  Cancer Res       Date:  1997-12-01       Impact factor: 12.701

6.  RIP mediates tumor necrosis factor receptor 1 activation of NF-kappaB but not Fas/APO-1-initiated apoptosis.

Authors:  A T Ting; F X Pimentel-Muiños; B Seed
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

7.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal.

Authors:  M A Kelliher; S Grimm; Y Ishida; F Kuo; B Z Stanger; P Leder
Journal:  Immunity       Date:  1998-03       Impact factor: 31.745

8.  Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway.

Authors:  L E Huang; J Gu; M Schau; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

9.  Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth.

Authors:  P H Maxwell; G U Dachs; J M Gleadle; L G Nicholls; A L Harris; I J Stratford; O Hankinson; C W Pugh; P J Ratcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

10.  Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine.

Authors:  G Melillo; L S Taylor; A Brooks; T Musso; G W Cox; L Varesio
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

View more
  65 in total

1.  Autophagy in cancer associated fibroblasts promotes tumor cell survival: Role of hypoxia, HIF1 induction and NFκB activation in the tumor stromal microenvironment.

Authors:  Ubaldo E Martinez-Outschoorn; Casey Trimmer; Zhao Lin; Diana Whitaker-Menezes; Barbara Chiavarina; Jie Zhou; Chengwang Wang; Stephanos Pavlides; Maria P Martinez-Cantarin; Franco Capozza; Agnieszka K Witkiewicz; Neal Flomenberg; Anthony Howell; Richard G Pestell; Jaime Caro; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2010-09-09       Impact factor: 4.534

2.  NF-kappaB driven cardioprotective gene programs; Hsp70.3 and cardioprotection after late ischemic preconditioning.

Authors:  Michael Tranter; Xiaoping Ren; Tiffany Forde; Michael E Wilhide; Jing Chen; Maureen A Sartor; Mario Medvedovic; W Keith Jones
Journal:  J Mol Cell Cardiol       Date:  2010-07-16       Impact factor: 5.000

3.  Synergistic up-regulation of vascular endothelial growth factor (VEGF) expression in macrophages by adenosine A2A receptor agonists and endotoxin involves transcriptional regulation via the hypoxia response element in the VEGF promoter.

Authors:  Madhuri Ramanathan; Grace Pinhal-Enfield; Irene Hao; Samuel Joseph Leibovich
Journal:  Mol Biol Cell       Date:  2006-10-25       Impact factor: 4.138

Review 4.  Hypoxic preconditioning protects against ischemic brain injury.

Authors:  Frank R Sharp; Ruiqiong Ran; Aigang Lu; Yang Tang; Kenneth I Strauss; Todd Glass; Tim Ardizzone; Myriam Bernaudin
Journal:  NeuroRx       Date:  2004-01

Review 5.  Unlocking mammalian regeneration through hypoxia inducible factor one alpha signaling.

Authors:  Kelsey G DeFrates; Daniela Franco; Ellen Heber-Katz; Phillip B Messersmith
Journal:  Biomaterials       Date:  2021-01-09       Impact factor: 12.479

6.  Gene expression profiling of the hypoxia signaling pathway in hypoxia-inducible factor 1alpha null mouse embryonic fibroblasts.

Authors:  Ajith Vengellur; Barbara G Woods; Heather E Ryan; Randall S Johnson; John J LaPres
Journal:  Gene Expr       Date:  2003

7.  Oxidative stress, gene expression, and protein changes induced in the human placenta during labor.

Authors:  Tereza Cindrova-Davies; Hong-Wa Yung; Jemma Johns; Olivera Spasic-Boskovic; Svitlana Korolchuk; Eric Jauniaux; Graham J Burton; D Stephen Charnock-Jones
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

8.  The expression of thioredoxin-1 in preterm delivery placenta.

Authors:  Junying Song; Xudong Dong; Yan Chen; Guixian Chen; Hong Liang; Hajime Nakamura; Junji Yodoi; Jie Bai
Journal:  Redox Rep       Date:  2012       Impact factor: 4.412

Review 9.  Hypoxia. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis.

Authors:  Barbara Muz; Moddasar N Khan; Serafim Kiriakidis; Ewa M Paleolog
Journal:  Arthritis Res Ther       Date:  2009-01-20       Impact factor: 5.156

Review 10.  Hypoxia. Regulation of NFkappaB signalling during inflammation: the role of hydroxylases.

Authors:  Kathryn M Oliver; Cormac T Taylor; Eoin P Cummins
Journal:  Arthritis Res Ther       Date:  2009-02-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.